QNTM
Quantum BioPharma·NASDAQ
--
--(--)
--
--(--)
7.27 / 10
Outperform
Analyst coverage is absent, but fund‑flow sentiment is strong with a 7.27/10 score. Overall inflow ratio is ~0.49; small‑cap inflows are positive while larger blocks show negative trends, indicating solid but selective buying pressure.
Fund Flow Rating
What is the market sentiment for QNTM?
- QNTM holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.27/10 (Outperform).
